LP-211

From Wikipedia, the free encyclopedia
Jump to: navigation, search
LP-211
LP-211 structure.png
Systematic (IUPAC) name
N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide
Clinical data
Legal status ?
Identifiers
ATC code ?
PubChem CID 25107716
Chemical data
Formula C30H34N4O 
Mol. mass 466.616 g/mol
 YesY (what is this?)  (verify)

LP-211 is a drug which acts as a potent and selective agonist at the 5HT7 serotonin receptor, with better brain penetration than older 5-HT7 agonists in the same series, and similar effects in animals.[1][2]

See also[edit]

References[edit]

  1. ^ Hedlund PB, Leopoldo M, Caccia S, Sarkisyan G, Fracasso C, Martelli G, Lacivita E, Berardi F, Perrone R (August 2010). "LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor". Neuroscience Letters 481 (1): 12–6. doi:10.1016/j.neulet.2010.06.036. PMC 2910240. PMID 20600619. 
  2. ^ Monti JM (August 2011). "Serotonin control of sleep-wake behavior". Sleep Medicine Reviews 15 (4): 269–81. doi:10.1016/j.smrv.2010.11.003. PMID 21459634.